Costs no higher with everolimus in heart transplant

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.476, 2005-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is everolimus useful in preventing allograft rejection and vasculopathy after heart transplant?

By Doggrell Sheila A

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 2, 2004-02 ,pp. : 161-163

Informa Healthcare

Access to resources Recommend Favorite

Everolimus better for matters of the heart

Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics and Pharmacogenetics of Everolimus in Renal Transplant Patients

By Moes Dirk Jan A.R. Press Rogier R. >

Clinical Pharmacokinetics, Vol. 51, Iss. 7, 2012-07 ,pp. : 467-480

Adis International

Access to resources Recommend Favorite

Everolimus evades acute rejection following renal transplant

Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Everolimus

By Chapman T.M. Perry C.M.

Drugs, Vol. 64, Iss. 8, 2004-01 ,pp. : 861-872

Adis International

Access to resources Recommend Favorite